<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00369044</url>
  </required_header>
  <id_info>
    <org_study_id>200608A</org_study_id>
    <nct_id>NCT00369044</nct_id>
  </id_info>
  <brief_title>Prednisone for Decompensated Congestive Heart Failure</brief_title>
  <official_title>Chronic Administration of Prednisone in Management of Patients With Decompensated Congestive Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hebei Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hebei Medical University</source>
  <brief_summary>
    <textblock>
      We designed this, randomized, double-blind, placebo-controlled trial to determine the
      clinical efficacy of chronic administration of prednisone on renal function and clinical
      status when added to standard care.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies showed that glucocorticoids could specifically dilate renal vessel, increase in GFR,
      and regulate synthesis and release of atrial natriuretic peptide (ANP), upregulate ANP
      receptors on vascular endothelial cells, leading to significant diuresis and natriuresis.
      Adding glucocorticoids to standard care may potentiate the diuretic and natriuretic effects
      of diuretics and improve renal function, thus improve the clinical outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <start_date>October 2006</start_date>
  <completion_date type="Anticipated">July 2008</completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in serum creatinine level, Patient and physician-assessed symptom scales at day 1, day 3, the end of week 1 and week 2</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Daily urine volume, changes in body weight, serum electrolyte levels at the end of week 1, week 2, respectively, and overall safety profile</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Heart Failure, Congestive</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>prednisone</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hospitalized with primary diagnosis of CHF

          -  Patients with normal cortical function

          -  LVEF &lt;40%

          -  Significant fluid overload, defined as ≥ 2 of the following

               -  Enlarged liver or ascites

               -  Peripheral or sacral edema ( ≥ 2+)

               -  Jugular venous distention ≥ 10 cm

               -  Pulmonary rales, pleural effusion on chest x-ray or orthopnea

        Exclusion Criteria:

          -  Severe stenotic valvular disease

          -  Serum creatinine &gt; 4 mg/dl

          -  Patient refusal

          -  Any signs of infection or any condition that would contraindicate an glucocorticoids
             use

          -  Poor controlled hypertension

          -  Poor controlled diabetes mellitus

          -  Active myocarditis

          -  Malignancy or other terminal illness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kunshen Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Hospital of Hebei Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The First Hospital of Hebei Medical University</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>050031</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Liu C, Chen H, Zhou C, Ji Z, Liu G, Gao Y, Tian L, Yao L, Zheng Y, Zhao Q, Liu K. Potent potentiating diuretic effects of prednisone in congestive heart failure. J Cardiovasc Pharmacol. 2006 Oct;48(4):173-6.</citation>
    <PMID>17086096</PMID>
  </reference>
  <verification_date>June 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 28, 2006</study_first_submitted>
  <study_first_submitted_qc>August 28, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2006</study_first_posted>
  <last_update_submitted>April 7, 2009</last_update_submitted>
  <last_update_submitted_qc>April 7, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 8, 2009</last_update_posted>
  <keyword>decompensated heart failure</keyword>
  <keyword>prednisone</keyword>
  <keyword>diuretics</keyword>
  <keyword>diuresis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

